RT Journal Article
SR Electronic
T1 Estimating the Effect of PrEP in Black Men Who Have Sex with Men: A Framework to Utilize Data from Multiple Non-Randomized Studies to Estimate Causal Effects
JF medRxiv
FD Cold Spring Harbor Laboratory Press
SP 2024.01.10.24301113
DO 10.1101/2024.01.10.24301113
A1 Meisner, Allison
A1 Xia, Fan
A1 Chan, Kwun C.G.
A1 Mayer, Kenneth
A1 Wheeler, Darrell
A1 Zangeneh, Sahar
A1 Donnell, Deborah
YR 2024
UL http://medrxiv.org/content/early/2024/03/05/2024.01.10.24301113.abstract
AB Black men who have sex with men (MSM) are disproportionately burdened by the HIV epidemic in the US. The effectiveness of pre-exposure prophylaxis (PrEP) in preventing HIV infection has been demonstrated through randomized placebo-controlled clinical trials in several populations. Importantly, no such trial has been conducted exclusively among Black MSM in the US, and it would be unethical and infeasible to do so now. To estimate the causal effects of PrEP access, initiation, and adherence on HIV risk, we utilized causal inference methods to combine data from two non-randomized studies that exclusively enrolled Black MSM. The estimated relative risks of HIV were: (i) 0.52 (95% confidence interval: 0.21, 1.22) for individuals with versus without PrEP access, (ii) 0.48 (0.12, 0.89) for individuals who initiated PrEP but were not adherent versus those who did not initiate, and (iii) 0.23 (0.02, 0.80) for individuals who were adherent to PrEP versus those who did not initiate. Beyond addressing the knowledge gap around the effect of PrEP in Black MSM in the US, which may have ramifications for public health, we have provided a framework to combine data from multiple non-randomized studies to estimate causal effects, which has broad utility.Competing Interest StatementThe authors have declared no competing interest.Clinical TrialNCT00951249, NCT01808352Funding StatementWe acknowledge funding from NIH U01 HL146242 and NIH P30 MH123248. Overall support for the HIV Prevention Trials Network (HPTN) is provided by the NIH under Award Numbers UM1AI068619 (HPTN Leadership and Operations Center), UM1AI068617 (HPTN Statistical and Data Management Center), and UM1AI068613 (HPTN Laboratory Center). Additional support for this study was provided by UM1AI069412.Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:The studies (HPTN 061 and HPTN 073) were reviewed and approved by the IRBs of each study site and all participants provided written informed consent, including for the data analysis presented in this work.I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.YesData and code to run this analysis are available at: https://github.com/meisnera/BMSM_PrEP.